Abstract:

Objective To learn about the clinical efficacy and safety of bronchoscopy intervention at different time points for children with refractory Mycoplasma pneumoniae pneumonia.Methods Retrospective analysis was performed in 142 children with RMPP diagnosed during hospitalization from January 2015 to January 2018,and according to the bronchoscopy intervention time, they were divided into early group(course of disease being 5 to 10 days), mid-term group(11 to 15 days) and late group(16 days or more). Compare the clinical data of three groups of children.Results (1) There were no significant differences in general information,clinical manifestations,inflammatory markers, or chest imaging scores among the three groups before bronchoscopy. (2) The hospitalization time,total fever period, cough disappearance time, and chest imaging absorption time in the early group were shorter than those in the mid-term and late groups (P<0.05).Conclusion (1)Bronchoscopy intervention has a significant effect and safety in the treatment of children with refractory Mycoplasma pneumoniae pneumonia.(2)Early intervention with bronchoscopy can shorten the hospitalization time, reducing the duration of fever and cough, and promote chest imaging absorption.

Key words:

Refractory Mycoplasma pneumoniae pneumonia, Bronchoscopy, Imaging, Children